-
Synthesis and Preclinical Evaluation of [Methylpiperazine-11C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase
Högnäsbacka, A. A., Poot, A. J., Kooijman, E., Schuit, R. C., Schreurs, M., Verlaan, M., Beaino, W., van Dongen, G. A. M. S., Vugts, D. J. & Windhorst, A. D., 14 Sept 2023, In: Journal of Medicinal Chemistry. 66, 17, p. 12130-12140 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor
Högnäsbacka, A., Poot, A. J., Kooijman, E., Schuit, R. C., Schreurs, M., Verlaan, M., van den Hoek, J., Heideman, D. A. M., Beaino, W., van Dongen, G. A. M. S., Vugts, D. J. & Windhorst, A. D., 1 May 2023, In: Nuclear medicine and biology. 120-121, 108349.Research output: Contribution to journal › Article › Academic › peer-review
-
Validation of a good manufacturing practice procedure for the production of [11C]AZD4747, a CNS penetrant KRASG12c inhibitor
Cortés González, M. A., Högnäsbacka, A. A., Halldin, C. & Schou, M., 2023, (E-pub ahead of print) In: Journal of Labelled Compounds and Radiopharmaceuticals.Research output: Contribution to journal › Article › Academic › peer-review
- All publications